Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/12 → 3/30/16 |
Funding
- Janssen Research and Development LLC: $248,540.00
12NHL14JJ BTK Inhibitor+Ibrutinib in Patients with Mantle Cell Lymphoma who Progress After Bortezomib
- Fleischman, Roger (PI)
- Hayslip, John (Former PI)